Navigation Links
Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
Date:2/21/2008

ican Federal Commission for the Protection against Sanitary Risk. ELAPRASE is now approved in 37 countries worldwide and sales for the year to December 31, 2007 were $181.8 million (2006: $23.6 million).

- In October 2007 ELAPRASE was launched in Japan, with sales and distribution managed by Genzyme Corporation. Shire's gross profit on the arrangement equates to an effective royalty of approximately 25% to 30%, but revenues will be recorded within product sales.

- REPLAGAL(R) - Fabry disease.

- REPLAGAL is now approved in 41 countries and sales for 2007 were up 22% to $143.9 million (2006: $117.7 million).

- In February 2007 REPLAGAL was launched in Japan through Shire's partner Dainippon Sumitomo Pharma Co., Ltd. Similar to ELAPRASE, Shire will record revenues within product sales.

Pipeline Highlights

Shire has expanded its product pipeline by in-licensing the following drug compounds and technologies in 2007:

- JUVISTA(R)

- In August 2007 Shire acquired exclusive rights to develop and commercialize JUVISTA worldwide (with the exception of EU member states) from Renovo Limited ("Renovo"). JUVISTA, which is being investigated for the prevention and reduction of scarring in connection with surgery, is in late Phase 2 development.

- Seven Phase 2 efficacy trials for JUVISTA have now been reported of which six demonstrated statistically significant efficacy. Phase 2 clinical trials in multiple other surgery types are ongoing and are expected to report during 2008 and 2009.

- Pharmacological chaperone compounds for Lysosomal Storage Disorders ("LSDs") - In November 2007 Shire in-licensed from Amicus Therapeutics, Inc. ("Amicus") the rights to three compounds in markets outside the US:

- AMIGAL(TM) for Fabry disease (Phase 2) received orphan drug designation by the EMEA, which may provide it with up to ten years market exclusivity in the EU;

- PLICERA(TM) for Gaucher disease (Phase 2) rec
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Correction Re Website
2. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
3. Shire Engages Palio
4. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
5. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
6. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire plc: Board Changes
9. David Mott Appointed Non Executive Director at Shire
10. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
11. Shire Divests Non-Core Product Portfolio to Almirall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... Athens, OH (PRWEB) May 16, 2013 ... freezer manufactured by Global Cooling, Inc., Athens, OH, USA, ... 8, 2013 by the International Society for Biological and ... Australia. The award, given to one product annually, recognizes ... energy efficient ultra-low temperature freezer. The award was ...
(Date:5/16/2013)... Auckland, New Zealand (PRWEB) May 16, 2013 ... Zealand, was invited to speak to doctors in China about ... across Australia and NZ, this was her first trip to ... , Dr. Hart visited Guangzhou and Fuzhou, home to 12 ... treatments in China is very high at this point in ...
(Date:5/16/2013)... (PRWEB) May 16, 2013 ... software solutions, today announces new Phase II SBIR ... the continued development of an open-source, high performance ... model-centric integration framework enables researchers to select only ... set of simulation, computation, or analysis tasks. ...
(Date:5/16/2013)... 16, 2013 Scientists at the Center for ... , and the California -based biopharmaceutical ... novel therapy for reversing memory decline in mice with ... significant cognitive improvement in advanced stage AD mice. The ... reversing cognitive decline for advanced stage AD mice, and ...
Breaking Biology Technology:Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3
... New England Biolabs has expanded its line of PCR reagents ... Start DNA Polymerases. Optimized blends of Taq and ... robust amplification across a wide range of templates, including routine, ... Vent increases the fidelity and robustness of Taq , ...
... 2011 QPS Holdings, LLC, a leading full-service ... support preclinical and clinical research and development, announced ... Preclinical Sciences (CTPS) from Taiwan,s Development Center for ... a division of QPS-Taiwan. QPS is ...
... Inc., a pharmaceutical company developing orally-available broad spectrum ... $45 million Series F financing. New Leaf Venture ... investors Pappas Ventures and Morningside Group, as well ... Partners, Asset Management Company and Frazier Healthcare Ventures. ...
Cached Biology Technology:New England Biolabs Introduces OneTaq™ DNA Polymerase, a Robust Solution for Routine and Difficult PCR 2QPS Expands Into Toxicology Services With Acquisition of the Preclinical Unit of DCB Taiwan 2Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157 2Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157 3Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157 4
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) ... The Endocrine Society (ENDO) 95th Annual Meeting in ... awards are meant to promote the entry of ... the mainstream of the basic science community and ... the ENDO 2013 Annual Meeting. , Awards are ...
(Date:5/16/2013)... to a fast food restaurant had a higher body ... from fast food, according to researchers at The University ... was particularly strong among those with a lower income. ... American Journal of Public Health indicates higher ... restaurant, and among lower-income African-Americans, the density, or number, ...
(Date:5/16/2013)... University scientists have shown a gene involved in neurodegenerative ... function of the circadian clock. , In a ... the gene, called Ataxin-2, keeps the clock responsible for ... gene, the rhythm of the fruit fly,s sleep-wake cycle ... difficult for the fly. , The discovery is ...
Breaking Biology News(10 mins):Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3Gene involved in neurodegeneration keeps clock running 2
... A new study led by a University of Florida ... the first evidence some of the fish swim directly to ... the ability to orient at large distances, with tiger sharks ... reaching specific resource areas about 30 miles away, said lead ...
... suicide worldwide each year, researchers and doctors do not ... thinking about or trying to commit suicide. An international ... Research Institute (IMIM) has participated, has devised the first ... of key importance to identify suicidal thoughts among people ...
... Researchers from all over the world will be at ... of Energy Joint Genome Institute 6th Annual Meeting, which ... energy generation and the environment. Keynote speeches will be ... Accelerator Center, and microbial ecologist Terry Hazen of Lawrence ...
Cached Biology News:New UF study shows some sharks follow 'mental map' to navigate seas 2New UF study shows some sharks follow 'mental map' to navigate seas 3First international index developed to predict suicidal behavior 2
... excellent ion chromatography system . The sensitive ... 0.01S to 5000S, houses the measuring cell in ... 4715, is available. Data processing is provided ... delivery is by the high pressure CE 4100 ...
The Mu-End™ Protein Truncation Kit provides a convenient method for generating a library of N-terminal and C-terminal protein deletions that can be expressed in E. coli....
... form culture flask is designed for culturing organisms requiring ... has a heavy beaded rim to protect against chipping ... is 38mm and takes a No. 6.5 rubber stopper. ... heat source smaller than the base of the flask. ...
...
Biology Products: